Royal Bank of Canada’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$53K Sell
1,558
-2,029
-57% -$69K ﹤0.01% 5527
2025
Q1
$114K Buy
3,587
+29
+0.8% +$922 ﹤0.01% 4781
2024
Q4
$139K Buy
3,558
+159
+5% +$6.21K ﹤0.01% 4657
2024
Q3
$153K Sell
3,399
-1,349
-28% -$60.7K ﹤0.01% 4584
2024
Q2
$199K Sell
4,748
-6,317
-57% -$265K ﹤0.01% 4397
2024
Q1
$504K Buy
11,065
+7,664
+225% +$349K ﹤0.01% 3568
2023
Q4
$157K Buy
3,401
+852
+33% +$39.3K ﹤0.01% 4764
2023
Q3
$103K Sell
2,549
-632
-20% -$25.5K ﹤0.01% 4885
2023
Q2
$154K Buy
3,181
+982
+45% +$47.5K ﹤0.01% 4544
2023
Q1
$108K Sell
2,199
-81
-4% -$3.98K ﹤0.01% 4745
2022
Q4
$115K Sell
2,280
-44,658
-95% -$2.25M ﹤0.01% 4877
2022
Q3
$2.36M Buy
46,938
+39,346
+518% +$1.98M ﹤0.01% 2351
2022
Q2
$371K Buy
7,592
+2,853
+60% +$139K ﹤0.01% 3892
2022
Q1
$285K Buy
4,739
+1,323
+39% +$79.6K ﹤0.01% 4300
2021
Q4
$271K Buy
3,416
+359
+12% +$28.5K ﹤0.01% 4526
2021
Q3
$271K Sell
3,057
-790
-21% -$70K ﹤0.01% 4393
2021
Q2
$383K Buy
3,847
+954
+33% +$95K ﹤0.01% 4052
2021
Q1
$260K Buy
2,893
+153
+6% +$13.8K ﹤0.01% 4264
2020
Q4
$259K Sell
2,740
-198
-7% -$18.7K ﹤0.01% 4150
2020
Q3
$212K Buy
2,938
+824
+39% +$59.5K ﹤0.01% 4048
2020
Q2
$148K Sell
2,114
-222
-10% -$15.5K ﹤0.01% 4165
2020
Q1
$116K Buy
2,336
+8
+0.3% +$397 ﹤0.01% 4203
2019
Q4
$145K Buy
2,328
+20
+0.9% +$1.25K ﹤0.01% 4271
2019
Q3
$115K Buy
+2,308
New +$115K ﹤0.01% 4162